title: Inotropic effects of angiotensin II on human cardiac muscle in vitro.
abstract: The direct effects of angiotensin II (Ang II) on human cardiac muscle were investigated using isolated trabecular muscles from failing and functionally normal hearts. Atrial and ventricular trabeculae were studied. Results demonstrated a positive inotropic effect of Ang II on human cardiac muscle. Comparison of the effects of Ang II among groups indicated that the responsiveness tended to be greater in atrial and normal muscle compared with failing muscle. Results of this study also demonstrated heterogeneity in the responsiveness to Ang II among human muscles, which was not correlated with patient age, sex, diagnosis, prior treatment with angiotensin converting enzyme inhibitor, or heart function. A significant correlation between response to Ang II and response to isoproterenol was demonstrated in failing ventricular trabeculae, which may suggest that defects in beta-adrenergic responsiveness in the failing human ventricle are accompanied by a loss of responsiveness to Ang II. Studies were extended to the Syrian cardiomyopathic hamster and its control. A dose-dependent inotropic response occurred in normal hamster ventricular muscle but was significantly diminished in cardiomyopathic muscle. Ang II did not shorten the timing of contraction, and pretreatment with adrenergic-blocking agents did not shift the dose-response curve, indicating that the response was not cyclic AMP mediated. This study demonstrates for the first time that Ang II can exert an inotropic effect directly on human cardiac muscle and confirms that there is a direct effect of Ang II on hamster cardiac muscle. The study further suggests, however, that the inotropic response to Ang II in cardiac muscle is heterogeneous and may be diminished by heart failure.
authors.affiliation: Department of Heart and Hypertension Research, Cleveland Clinic Foundation, Ohio 44195-5069.
authors.forename: C S
authors.initials: CS
authors.lastname: Moravec
authors.forename: M D
authors.initials: MD
authors.lastname: Schluchter
authors.forename: L
authors.initials: L
authors.lastname: Paranandi
authors.forename: B
authors.initials: B
authors.lastname: Czerska
authors.forename: R W
authors.initials: RW
authors.lastname: Stewart
authors.forename: E
authors.initials: E
authors.lastname: Rosenkranz
authors.forename: M
authors.initials: M
authors.lastname: Bond
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D002303:Cardiac Output, Low / Q000503:physiopathology; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D006321:Heart / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D008647:Mesocricetus; D009200:Myocardial Contraction / Q000187:drug effects*; D010210:Papillary Muscles / Q000187:drug effects; D012016:Reference Values
chemical_list: D000804:Angiotensin II